Target intelligence / Profile preview

Candida krusei surface antigens

Molecular classification
Cell wall component, Glycoprotein, Polysaccharide, Fungal antigen
01

Overview

Candida krusei surface antigens represent a diverse group of molecules located on the outermost layer of the fungal cell wall, including mannoproteins, beta-glucans, and chitin (Source: NCBI, PMC4202231). These antigens play critical roles in maintaining structural integrity, facilitating adhesion to host tissues, and modulating the host immune response during infection (Source: Mycology Online). Candida krusei (also known as Pichia kudriavzevii) is a significant opportunistic pathogen, particularly noted for its intrinsic resistance to fluconazole, making its surface components vital targets for alternative therapeutic strategies (Source: CDC). Drugs such as echinocandins target the synthesis of specific surface components like (1,3)-beta-D-glucan, leading to cell wall instability and lysis (Source: FDA). Additionally, these antigens serve as important diagnostic biomarkers and are being explored as potential targets for vaccine development and monoclonal antibody therapies to combat invasive candidiasis (Source: PubMed, 28604330). The unique composition of the C. krusei cell wall contributes to its environmental resilience and its ability to colonize diverse niches within the human host (Source: StatPearls, NBK459131). Understanding these surface structures is essential for developing precision diagnostics that can distinguish C. krusei from other Candida species (Source: Journal of Fungi).

Other names
Pichia kudriavzevii surface antigensC. krusei cell wall antigensCandida krusei cell wall proteinsIssatchenkia orientalis surface antigens
02

Mechanism of action

Inhibition of (1,3)-beta-D-glucan synthase (echinocandins); binding to ergosterol to form membrane pores (polyenes); inhibition of lanosterol 14-alpha-demethylase (azoles).

03

Biological functions

Cell wall organizationAdhesionImmune evasionPathogenesisHost-pathogen interaction
04

Disease associations

CandidiasisFungemiaInvasive fungal infectionNosocomial infection
05

Safety considerations

Intrinsic resistance to fluconazoleHepatotoxicityNephrotoxicity (especially with Amphotericin B)Infusion-related reactionsPotential for paradoxical growth effect with echinocandins
06

Interacting drugs

Caspofungin

6 more in the full profile.

07

Biomarkers

(1,3)-beta-D-glucan (BDG)Mannan antigenAnti-mannan antibodiesC. krusei-specific DNA sequences

Beyond the preview

Go deeper on Candida krusei surface antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Candida krusei surface antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call